These B-1 Lancers and B-52 bombers are not lifting light — they are launching heavy for strike missions with the kind of weight that makes every takeoff look punishing. The runway disappears under ...

This is read by an automated voice. Please report any issues or inconsistencies here. Whether they’re using weekly shots or daily pills, more Americans than ever are turning to anti-obesity drugs to ...

Clinical evidence has long suggested that the use of GLP-1 medications is linked to lower substance use. It’s also been speculated among patients taking the medications. Social drinkers, for example, ...

Dietary trends are nothing new. For decades, a variety of weight loss techniques have cropped up and faded away, from Weight Watchers plans and Atkins diets to intermittent fasting and paleo ...

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. GLP-1s are ...

Lawsuits don’t often end in partnerships. And yet that is the strange but true tale involving Hims & Hers and drug manufacturer Novo Nordisk. Last month, Novo Nordisk sued Hims & Hers over its sale ...

A war between some of the biggest names in weight loss has abruptly ended in a mutually beneficial truce—one that might have major implications for the average person seeking obesity treatment. On ...

Could Ozempic and other GLP⁠-1s help ADHD symptoms? GLP-1 drugs like Ozempic and Zepbound have transformed medical treatment for obesity and Type 2 diabetes. Some people with ADHD who take the drugs ...

Equipped with a 48V 18Ah (864Wh) lithium battery, up from the previous 48V 15Ah. Under ideal pedal-assist conditions, range increases from approximately 55 miles to up to 80 miles, supporting longer ...

Share on Pinterest GLP-1s linked to higher osteoporosis risk but they may bring some benefits, too, new studies find. Image credit: SweetBunFactory/Getty Images A large percentage of Americans are ...

Zongertinib gained accelerated approval for unresectable/metastatic HER2 kinase-domain–mutant nonsquamous NSCLC, with 76% ORR and DOR ≥12 months in 44%. AMPLIFY ...

Evidence is mounting that the wildly popular weight-loss medicines known as GLP-1s may also hold potential for treating addiction, and the field may be on the verge of obtaining desperately needed ...